Stock NXOA NICOX SA
Add to a list
To use this feature you must be a member
Log inSign up

News Nicox SA BOERSE MUENCHEN

Equities

NXOA

FR0013018124

Market Closed - BOERSE MUENCHEN
Other stock markets
 03:44:04 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.1878 EUR 0.00% Intraday chart for Nicox SA -6.57% -56.48%
Jun. 19 Nicox: successful capital increase CF
May. 30 Nicox : launch of a capital increase CF

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nicox: 2024 Ordinary Shareholder Meeting
GL
Nicox : announces the success of its equity offering with preemptive rights through an issue of stock with warrants, for a total amount of €3.3 million, extending its cash runway to continue the development of NCX 470
PU
Nicox: successful capital increase
CF
Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024
PU
Nicox : Suggested agenda and summary of the resolutions submitted to the approval of the shareholder meetings (translation for information purposes)
PU
Nicox : Form to request documents provided for in articles R 225-83 of the French “Code de commerce”
PU
Nicox : launch of a capital increase
CF
Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024
GL
Nicox’s Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024
GL
Nicox, Second notice of the Ordinary and Extraordinary Shareholders Meeting on May 6, 2024 and appointment of an ad hoc agent
AQ
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent
GL
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent
AQ
Nicox: cash position of 9.1 million euros at the end of March
CF
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results
GL
Nicox, 2024 Ordinary and Extraordinary Shareholder Meeting
AQ
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
GL
Nicox : Shareholder Letter
PU
Nicox's Shareholder Letter
GL
Nicox's Shareholder Letter
AQ
Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of Ophthalmology
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALCOX Stock
  4. NXOA Stock
  5. News Nicox SA